{
    "clinical_study": {
        "@rank": "97676", 
        "brief_summary": {
            "textblock": "RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing\n      so they stop growing or die. Combining more than one drug may kill more cancer cells.\n\n      PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy consisting of\n      cytarabine plus idarubicin in treating patients who have relapsed acute myelogenous\n      leukemia."
        }, 
        "brief_title": "Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia", 
        "condition": "Leukemia", 
        "condition_browse": {
            "mesh_term": [
                "Leukemia", 
                "Leukemia, Myeloid, Acute", 
                "Leukemia, Myeloid"
            ]
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES: I. Assess the feasibility and efficacy of intermediate dose cytarabine plus\n      idarubicin followed by low dose cytarabine in patients with relapsed acute myelogenous\n      leukemia.\n\n      OUTLINE: This is a multicenter study. Patients receive intermediate dose cytarabine IV over\n      2 hours twice a day on days 1-5, idarubicin IV over 24 hours on days 1, 3, and 5, and low\n      dose cytarabine IV over 24 hours on days 6-15. If patients achieve complete remission by day\n      35, this regimen is repeated once. If patients achieve partial remission by day 35, this\n      regimen is repeated, except with an additional day of idarubicin on day 7. If these patients\n      then achieve complete remission by day 70, the regimen is repeated. Patients may then\n      undergo stem cell transplantation within 6 months of achieving complete remission. Patients\n      who have an HLA identical sibling available receive an allogeneic transplant; others receive\n      an autologous transplant. Patients are followed monthly for 1 year, every 3 months for 3\n      years, then every 6 months thereafter.\n\n      PROJECTED ACCRUAL: A total of 24-60 patients will be accrued for this study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS: First bone marrow relapse of primary acute myelogenous leukemia\n        (AML), all subtypes except M3 OR First bone marrow relapse of secondary AML that occurred\n        after other malignancies, but cured, or after alkylating agents and/or radiotherapy, or\n        after myelodysplastic syndrome No previously untreated AML or second or subsequent relapse\n        of AML No isolated extramedullar localization of AML Must have achieved a first complete\n        remission No leukemias after other myeloproliferative diseases\n\n        PATIENT CHARACTERISTICS: Age: 15 to 60 Performance status: WHO 0-2 Life expectancy: Not\n        specified Hematopoietic: Not specified Hepatic: Bilirubin no greater than 1.5 times upper\n        limit of normal (ULN) Alkaline phosphatase no greater than 1.5 times ULN AST no greater\n        than 1.5 times ULN Renal: Creatinine no greater than 1.5 times ULN Cardiovascular: No\n        cardiac contraindications to anthracycline chemotherapy Ventricular ejection fraction at\n        least 45% Other: No uncontrolled infection No concurrent severe neurological or\n        psychiatric disease No other progressive malignant nonhematological disease\n\n        PRIOR CONCURRENT THERAPY: Biologic therapy: No prior allogeneic or autologous bone marrow\n        or peripheral stem cell transplant Chemotherapy: See Disease Characteristics Endocrine\n        therapy: Not specified Radiotherapy: See Disease Characteristics Surgery: Not specified"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "15 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 1, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00003758", 
            "org_study_id": "CDR0000066882", 
            "secondary_id": "EORTC-06956"
        }, 
        "intervention": [
            {
                "intervention_name": "cytarabine", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "idarubicin", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "allogeneic bone marrow transplantation", 
                "intervention_type": "Procedure"
            }, 
            {
                "intervention_name": "autologous bone marrow transplantation", 
                "intervention_type": "Procedure"
            }, 
            {
                "intervention_name": "peripheral blood stem cell transplantation", 
                "intervention_type": "Procedure"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Cytarabine", 
                "Idarubicin"
            ]
        }, 
        "keyword": [
            "recurrent childhood acute myeloid leukemia", 
            "recurrent adult acute myeloid leukemia", 
            "adult acute monoblastic leukemia and acute monocytic leukemia (M5)", 
            "childhood acute monoblastic leukemia and acute monocytic leukemia (M5)", 
            "adult acute erythroid leukemia (M6)", 
            "adult acute myeloblastic leukemia without maturation (M1)", 
            "adult acute myeloblastic leukemia with maturation (M2)", 
            "adult acute myelomonocytic leukemia (M4)", 
            "adult acute eosinophilic leukemia", 
            "adult acute basophilic leukemia", 
            "adult acute megakaryoblastic leukemia (M7)", 
            "childhood acute myeloblastic leukemia without maturation (M1)", 
            "childhood acute myeloblastic leukemia with maturation (M2)", 
            "childhood acute myelomonocytic leukemia (M4)", 
            "childhood acute erythroleukemia (M6)", 
            "childhood acute eosinophilic leukemia", 
            "childhood acute basophilic leukemia", 
            "childhood acute megakaryocytic leukemia (M7)", 
            "adult acute minimally differentiated myeloid leukemia (M0)", 
            "childhood acute minimally differentiated myeloid leukemia (M0)"
        ], 
        "lastchanged_date": "February 6, 2009", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/EORTC-06956"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Antwerp", 
                        "country": "Belgium", 
                        "zip": "2020"
                    }, 
                    "name": "Algemeen Ziekenhuis Middelheim"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brugge", 
                        "country": "Belgium", 
                        "zip": "8000"
                    }, 
                    "name": "A.Z. St. Jan"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brussels", 
                        "country": "Belgium", 
                        "zip": "1000"
                    }, 
                    "name": "Institut Jules Bordet"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Edegem", 
                        "country": "Belgium", 
                        "zip": "B-2650"
                    }, 
                    "name": "Universitair Ziekenhuis Antwerpen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zagreb", 
                        "country": "Croatia", 
                        "zip": "41000"
                    }, 
                    "name": "Medical School/University of Zagreb"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zagreb", 
                        "country": "Croatia", 
                        "zip": "41000"
                    }, 
                    "name": "University Hospital Rebro"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75743"
                    }, 
                    "name": "Hopital Necker"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75181"
                    }, 
                    "name": "Hotel Dieu de Paris"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rome", 
                        "country": "Italy", 
                        "zip": "00144"
                    }, 
                    "name": "Ospedale San Eugenio"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rome", 
                        "country": "Italy", 
                        "zip": "00168"
                    }, 
                    "name": "Policlinico A. Gemelli - Universita Cattolica del Sacro Cuore"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "'s-Hertogenbosch", 
                        "country": "Netherlands", 
                        "zip": "5211 NL"
                    }, 
                    "name": "Groot Ziekengasthuis 's-Hertogenbosch"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leiden", 
                        "country": "Netherlands", 
                        "zip": "2300 ZA"
                    }, 
                    "name": "Leiden University Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nijmegen", 
                        "country": "Netherlands", 
                        "zip": "NL-6252 HB"
                    }, 
                    "name": "University Medical Center Nijmegen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Veldhoven", 
                        "country": "Netherlands", 
                        "zip": "5500 MB       DB"
                    }, 
                    "name": "Sint Joseph Ziekenhuis"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Porto", 
                        "country": "Portugal", 
                        "zip": "4200"
                    }, 
                    "name": "Hospital Escolar San Joao"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ankara", 
                        "country": "Turkey", 
                        "zip": "06100"
                    }, 
                    "name": "Ibn-i Sina Hospital, Ankara Univeristy"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "Croatia", 
                "France", 
                "Italy", 
                "Netherlands", 
                "Portugal", 
                "Turkey"
            ]
        }, 
        "official_title": "Treatment of Relapsed Acute Myelogenous Leukemia Consisting of Intermediate Dose Cytosine Arabinoside (ARA-C) Plus Interspaced Continuous Infusion Idarubicin, Followed by Continuous Infusion of Low-Dose ARA-C, A Phase II Study by the EORTC-LCG", 
        "overall_official": {
            "affiliation": "Universitair Medisch Centrum St. Radboud - Nijmegen", 
            "last_name": "Petra Muus, MD, PhD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00003758"
        }, 
        "source": "National Cancer Institute (NCI)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "European Organisation for Research and Treatment of Cancer - EORTC", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 1998", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2001"
    }, 
    "geocoordinates": {
        "A.Z. St. Jan": "51.211 3.225", 
        "Algemeen Ziekenhuis Middelheim": "51.219 4.403", 
        "Groot Ziekengasthuis 's-Hertogenbosch": "51.698 5.317", 
        "Hopital Necker": "48.857 2.352", 
        "Hospital Escolar San Joao": "41.15 -8.61", 
        "Hotel Dieu de Paris": "48.857 2.352", 
        "Ibn-i Sina Hospital, Ankara Univeristy": "39.921 32.854", 
        "Institut Jules Bordet": "50.85 4.352", 
        "Leiden University Medical Center": "52.16 4.494", 
        "Medical School/University of Zagreb": "45.815 15.979", 
        "Ospedale San Eugenio": "41.891 12.494", 
        "Policlinico A. Gemelli - Universita Cattolica del Sacro Cuore": "41.891 12.494", 
        "Sint Joseph Ziekenhuis": "51.418 5.405", 
        "Universitair Ziekenhuis Antwerpen": "51.153 4.438", 
        "University Hospital Rebro": "45.815 15.979", 
        "University Medical Center Nijmegen": "51.843 5.855"
    }
}